NanoString Technologies, Inc.

Equities

NSTGQ

US63009R1095

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
0.2 USD +15.87% Intraday chart for NanoString Technologies, Inc. +166.67% -73.28%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Notice of Successful Bidder Filed by NanoString Technologies, Inc. CI
Bruker Corporation entered into an agreement to acquire Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $390 million. CI
North American Morning Briefing : Powell Comments, -2- DJ
Joint Reorganization Plan and Disclosure Statement Filed by NanoString Technologies, Inc. CI
North American Morning Briefing : Stocks Seen -2- DJ
North American Morning Briefing : Markets Steady -2- DJ
DIP Financing Approved for NanoString Technologies, Inc. CI
North American Morning Briefing : Stock Futures -2- DJ
Motion for Asset Sale Filed by NanoString Technologies, Inc. CI
Patient Square Capital, LP agreed to acquire Substantially all assets of global business operations from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $220 million. CI
NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from NASDAQ Composite Index CI
Canaccord Genuity Downgrades NanoString Technologies to Hold From Buy, Adjusts Price Target to $0.25 From $1.50 MT
Top Midday Gainers MT
NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from S&P Global BMI Index CI
NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from S&P TMI Index CI
Interim DIP Financing Approved for NanoString Technologies, Inc. CI
Motion for Joint Administration Approved for NanoString Technologies, Inc. CI
Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday MT
NanoString Starts Chapter 11 Bankruptcy; Exploring Strategic Options, Including Potential Sale MT
Motion for Joint Administration Filed by NanoString Technologies, Inc. CI
NanoString Technologies, Inc. Filed for Bankruptcy CI
NanoString Explores Strategic Alternatives CI
Nanostring Launches the CosMx 6,000 Plex RNA Assay and Showcases Whole Transcriptome Imaging Capability CI
Transcript : NanoString Technologies, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 05:15 PM
NanoString Technologies, Inc. Releases the First Public Dataset of the Whole Transcriptome Obtained At True Single-Cell Resolution on the CosMx Spatial Molecular Imager CI
Chart NanoString Technologies, Inc.
More charts
NanoString Technologies, Inc. is a provider of life science tools for discovery and translational research. It develops, manufactures, and markets technologies of biological materials for life science researchers in the fields of genomics and proteomics. Its product platforms include nCounter Analysis System (nCounter), CosMx Spatial Molecular Imager, AtoMx Spatial Informatics Platform, and GeoMx Digital Spatial Profiler (GeoMx DSP). Its nCounter is a multi-application, digital detection and counting system which directly profiles hundreds of molecules simultaneously, using optical barcoding chemistry. Its nCounter platform is based on automated instruments that prepare and analyze biological samples using reagents. GeoMx DSP is used to analyze selected regions of an intact biological sample without the need to break down the sample, enabling researchers to see how gene expression might vary across those regions. Its CosMx Spatial Molecular Imager is a spatial biology product platform.
Related indices
More about the company
  1. Stock Market
  2. Equities
  3. NSTGQ Stock
  4. News NanoString Technologies, Inc.
  5. NanoString Technologies : Morgan Stanley Adjusts NanoString Technologies PT to $70 From $55, Maintains Equal Weight Rating